Bioservo Technologies AB Stock

Equities

10B

SE0009779085

Advanced Medical Equipment & Technology

End-of-day quote BOERSE MUENCHEN 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
0.05 EUR 0.00% Intraday chart for Bioservo Technologies AB 0.00% 0.00%

Financials

Sales 2021 10.53M 962K 900K Sales 2022 13.76M 1.26M 1.18M Capitalization 47.84M 4.37M 4.09M
Net income 2021 -34M -3.11M -2.91M Net income 2022 -50M -4.57M -4.27M EV / Sales 2021 12.2 x
Net cash position 2021 51.52M 4.71M 4.4M Net cash position 2022 25.01M 2.29M 2.14M EV / Sales 2022 1.66 x
P/E ratio 2021
-4.55 x
P/E ratio 2022
-0.66 x
Employees 20
Yield 2021 *
-
Yield 2022
-
Free-Float 41.03%
More Fundamentals * Assessed data
Dynamic Chart
1 week
0.05
Extreme 0.05
0.05
1 month
0.05
Extreme 0.05
0.05
Current year
0.05
Extreme 0.05
0.05
1 year
0.05
Extreme 0.05
0.07
3 years
0.05
Extreme 0.05
1.51
5 years
0.05
Extreme 0.05
2.24
10 years
0.05
Extreme 0.05
2.30
More quotes
Date Price Change
24-04-26 0.05 0.00%
24-04-25 0.05 0.00%
24-04-24 0.05 0.00%
24-04-23 0.05 0.00%
24-04-22 0.05 0.00%

End-of-day quote BOERSE MUENCHEN, April 25, 2024

More quotes
Bioservo Technologies AB is a Sweden-based company within wearable technologies based on bionic soft robotics. It is engaged in developing, producing and selling muscle strengthening equipment based on the patented SEM Technology (Soft Extra Muscle Technology). The technology implies so called intention detection logic that activates the support if the wearer initiates movement with a natural and intuitive movement. This is achieved by sensors that detect the user’s action and strengthens this action by activating the motors. Its main product is a SEM Glove. The products are designed for people that have an impaired grip strength caused by injured nerves, weakening in the muscles or pain in the muscles/muscular attachments. The product is applicable in the healthcare and industry sectors.
More about the company

Quarterly revenue - Rate of surprise